Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce A Perkins

Showing results (201-210 of 247) with videos related to

Pageof 25
Sort By:
Plos One|May 1, 2018
Validity of a point-of-care nerve conduction device for polyneuropathy identification in older adults with diabetes: Results from the Canadian Study of Longevity in Type 1 DiabetesDaniel Scarr, Leif E Lovblom, Nancy Cardinez, et al.
Diabetes Care|February 1, 2024
Neuropathic Pain With and Without Diabetic Peripheral Neuropathy in Type 1 DiabetesBarbara H Braffett, Laure El Ghormli, James W Albers, et al.
Diabetes, Obesity & Metabolism|December 21, 2019
Low-dose empagliflozin as adjunct-to-insulin therapy in type 1 diabetes: A valid modelling and simulation analysis to confirm efficacyBruce A Perkins, Nima Soleymanlou, Julio Rosenstock, et al.
Diabetes Care|April 23, 2025
Capillary Ketone Level and Future Ketoacidosis Risk in Patients With Type 1 Diabetes Using Sodium-Glucose Cotransporter InhibitorsPriya Bapat, Sharon Dhaliwal, Cimon Song, et al.
Journal of Diabetes and Its Complications|October 6, 2022
Renal hemodynamic dysfunction and neuropathy in longstanding type 1 diabetes: Results from the Canadian study of longevity in type 1 diabetesYuliya Lytvyn, Rehab Albakr, Petter Bjornstad, et al.
Diabetes Technology & Therapeutics|October 10, 2024
Insulin Pump Use and Diabetic Ketoacidosis Risk in Type 1 Diabetes: Secular Trends over Four DecadesDalton R Budhram, Priya Bapat, Abdulmohsen Bakhsh, et al.
Diabetes Care|November 10, 2017
Diabetes Care Disparities in Long-standing Type 1 Diabetes in Canada and the U.S.: A Cross-sectional ComparisonAlanna Weisman, Leif E Lovblom, Hillary A Keenan, et al.
Diabetes Care|March 7, 2020
Rapid Corneal Nerve Fiber Loss: A Marker of Diabetic Neuropathy Onset and ProgressionEvan J H Lewis, Leif E Lovblom, Maryam Ferdousi, et al.
Journal of Diabetes and Its Complications|February 6, 2022
The association between physical activity time and neuropathy in longstanding type 1 diabetes: A cross-sectional analysis of the Canadian study of longevity in type 1 diabetesEvan J H Lewis, Leif E Lovblom, Sebastien Lanctot, et al.
Canadian Journal of Diabetes|May 19, 2026
A Patient-Clinician Co-Designed Infographic for Diabetic Ketoacidosis Education in Type 1 DiabetesMary Rose Waniss, Wajeeha Cheema, Talha Cheema, et al.
Pageof 25

Showing results (201-210 of 247) with videos related to

Sort By:
Pageof 25
Plos One|May 1, 2018
Validity of a point-of-care nerve conduction device for polyneuropathy identification in older adults with diabetes: Results from the Canadian Study of Longevity in Type 1 DiabetesDaniel Scarr, Leif E Lovblom, Nancy Cardinez, et al.
Diabetes Care|February 1, 2024
Neuropathic Pain With and Without Diabetic Peripheral Neuropathy in Type 1 DiabetesBarbara H Braffett, Laure El Ghormli, James W Albers, et al.
Diabetes, Obesity & Metabolism|December 21, 2019
Low-dose empagliflozin as adjunct-to-insulin therapy in type 1 diabetes: A valid modelling and simulation analysis to confirm efficacyBruce A Perkins, Nima Soleymanlou, Julio Rosenstock, et al.
Diabetes Care|April 23, 2025
Capillary Ketone Level and Future Ketoacidosis Risk in Patients With Type 1 Diabetes Using Sodium-Glucose Cotransporter InhibitorsPriya Bapat, Sharon Dhaliwal, Cimon Song, et al.
Journal of Diabetes and Its Complications|October 6, 2022
Renal hemodynamic dysfunction and neuropathy in longstanding type 1 diabetes: Results from the Canadian study of longevity in type 1 diabetesYuliya Lytvyn, Rehab Albakr, Petter Bjornstad, et al.
Diabetes Technology & Therapeutics|October 10, 2024
Insulin Pump Use and Diabetic Ketoacidosis Risk in Type 1 Diabetes: Secular Trends over Four DecadesDalton R Budhram, Priya Bapat, Abdulmohsen Bakhsh, et al.
Diabetes Care|November 10, 2017
Diabetes Care Disparities in Long-standing Type 1 Diabetes in Canada and the U.S.: A Cross-sectional ComparisonAlanna Weisman, Leif E Lovblom, Hillary A Keenan, et al.
Diabetes Care|March 7, 2020
Rapid Corneal Nerve Fiber Loss: A Marker of Diabetic Neuropathy Onset and ProgressionEvan J H Lewis, Leif E Lovblom, Maryam Ferdousi, et al.
Journal of Diabetes and Its Complications|February 6, 2022
The association between physical activity time and neuropathy in longstanding type 1 diabetes: A cross-sectional analysis of the Canadian study of longevity in type 1 diabetesEvan J H Lewis, Leif E Lovblom, Sebastien Lanctot, et al.
Canadian Journal of Diabetes|May 19, 2026
A Patient-Clinician Co-Designed Infographic for Diabetic Ketoacidosis Education in Type 1 DiabetesMary Rose Waniss, Wajeeha Cheema, Talha Cheema, et al.
Pageof 25